Top 9 manufacturers in Transitional Cell Cancer Therapeutics Market
By Prof Researh
Updated 01:40:28 February 15, 2020
.
Updated 01:40:28 February 15, 2020
Prof Resear published a new Market report on Transitional Cell Cancer Therapeutics Market. It present the largest 9 manufacruers in Transitional Cell Cancer Therapeutics Market. The report is a professional and in-depth study on the current state of the global Transitional Cell Cancer Therapeutics market with a focus on the Chinese market. The report provides key statistics on market of Transitional Cell Cancer Therapeutics. It is a valuable source of guidance and direction for companies and individuals interested in Transitional Cell Cancer Therapeutics industry.
.
AstraZeneca
AstraZeneca PLC’s ISS Governance QualityScore as of July 29, 2019 is 3. The pillar scores are Audit: 1; Board: 5; Shareholder Rights: 1; Compensation: 1. Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. You are about to access AstraZeneca historic archive material. Any reference in these archives to AstraZeneca products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. AstraZeneca focuses its operations on eight therapeutic areas, including gastrointestinal, oncology, cardiovascular, respiratory, central nervous system, pain control, anaesthesia , and infection ...
Roche
Ref A: 51369A828E434138859BD2A02587F1E7 Ref B: SJCEDGE0418 Ref C: 2020-02-14T17:40:07Z
Bristol-Myers Squibb
Ref A: E1F494D4C33044A08D35C880ACFD079B Ref B: SJCEDGE0412 Ref C: 2020-02-14T17:40:09Z
Pfizer
Ref A: CD1EEBE9B11A4ACDBD59BA78AED35A88 Ref B: SJCEDGE0207 Ref C: 2020-02-14T17:40:12Z
Exelixis
Exelixis , Inc ., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. Nov 09, 2019 · Exelixis , Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. It offers products under the brands of Cometriq, Cabometyx, and Cotellic. Aug 30, 2019 · Profile : Exelixis Inc (EXEL .O) Exelixis , Inc., incorporated on November 15, 1994, is a biopharmaceutical company. The Company is focused on discovery, development and …
Eisai
Ref A: 5D277CA53D644831966DC45121E5C45C Ref B: SJCEDGE0219 Ref C: 2020-02-14T17:40:15Z
Merck
Ref A: 8FD5822A49FC453985C6F87BD677DF6F Ref B: SJCEDGE0218 Ref C: 2020-02-14T17:40:17Z
Eli Lilly
Ref A: 588CFABF54864BF5BCF827F792BB5D5C Ref B: SJCEDGE0421 Ref C: 2020-02-14T17:40:23Z
Celgene
Ref A: 9D0033053D8640EC91EBEF80BE1ED87D Ref B: SJCEDGE0221 Ref C: 2020-02-14T17:40:27Z